Just two multinational pharmaceutical manufacturers have been selected to supply drugs to 11 major Chinese cities, as a government pilot program designed to glean lower drug prices goes into effect. The two firms, AstraZeneca and Bristol-Myers Squibb, will supply key drugs at... Read More
As spending on pharmaceuticals continues to accelerate in Japan, the government is exploring ways to control the surging costs of drugs essential for maintaining the health of its aging population. The Ministry of Finance plans to call for cuts to the standard... Read More
More than 4,000 food and drug products have been approved for sale in the Philippines since November 2018, as authorities speed to clear backlogs in the permitting process built up over years of neglect. The move by the Food and Drug Administration... Read More
Legal protections for pharmaceutical patents registered in South Korea made significant advances in 2018, with rulings by the courts and moves by the legislature to bolster intellectual property rights for foreign firms doing business in the country. In the most significant step... Read More
With Singapore continuing to attract top pharmaceutical companies, clinical research and biomedical manufacturing opportunities abound. Indeed between 2000 and 2015, the number of clinical research programs conducted in Singapore jumped by 30%. Today, six out of the top 10 drugs produced globally... Read More
Drugs needed to treat emergency room patients are often in short supply or unavailable in Chinese hospitals, according to a joint study by researchers in Australia and China released October 9. The drug shortage is serious and is having significant effects on... Read More
Seeking to stem widespread tobacco dependency in a country that is the largest producer and consumer in the world, Chinese cities are increasingly implementing strict new restrictions on smoking in public. This November, Xi’an, the capital of Shaanxi province in northwest China... Read More
Growth and interest in biotechnology is growing in key Asian markets, driven by increased government spending, a loosening of regulations, price reforms and private sector funding. China leads Asia in biotech research and development, number of companies, jobs and IPOs. The government... Read More
Moving to implement a program to speed the review and approval of dozens of drugs sold abroad but not yet approved in China, the China Food and Drug Administration (CFDA) has established special channels to approve clinically urgently listed new drugs. The... Read More
With rates of hepatitis B infection higher in Asia than anywhere else on the globe, deaths from liver cancer are an overwhelmingly Asian phenomenon. Almost 80 percent of cases and deaths from liver cancer occur on the Asian continent, according to the... Read More